The goal of the SCORE Program at Florida A&M University (FAMU) is to strengthen and expand state of the art biomedical research at the institution. The main objectives of the program will be to enhance the research infrastructure, attract and recruit highly qualified new minority biomedical investigators, stimulate research enthusiasm among existing faculty and increased biomedical investigators, stimulate research enthusiasm among existing faculty and increase biomedical research productivity and scientific competitiveness in the institution. The main objectives of the program will be to enhance the research infrastructure, attract and recruit highly qualified new minority biomedical investigators, stimulate research enthusiasm among existing faculty and increase biomedical research productivity and scientific competitiveness in the institution. The final outcome of such an institutional commitment should be the establishment of a vigorous biomedical research program with active investigators who will regularly publish their research findings in respectable peer-reviewed scientific journals as well as present their work in national and international meetings. Every effort will also be made to secure mainstream funding like the R01 grant. In this proposal, seventeen (17) SCORE subprojects proposals are currently submitted after a thorough pre-submission review process aided by internal and external reviewers. The proposed disciplines focus on the area of pharmacology, medicinal chemistry, biochemistry, molecular biology and toxicology. The Program will work very closely with FAMU's RISE Program to maximize the success of the proposed research activities. An effective evaluation plan is proposed to measure the stated goals and objectives of the Program. Formative and summative evaluation methods will be incorporated to review the achievements of the proposed research activities in the Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
3S06GM008111-30S1
Application #
6459284
Study Section
Minority Programs Review Committee (MPRC)
Project Start
1978-06-01
Project End
2005-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
30
Fiscal Year
2002
Total Cost
$1
Indirect Cost
Name
Florida Agricultural and Mechanical University
Department
Type
Schools of Pharmacy
DUNS #
City
Tallahassee
State
FL
Country
United States
Zip Code
32307
Johnston, Jermaine G; Pollock, David M (2018) Circadian regulation of renal function. Free Radic Biol Med 119:93-107
Adams, Mark K; Lee, Seung-Ah; Belyaeva, Olga V et al. (2017) Characterization of human short chain dehydrogenase/reductase SDR16C family members related to retinol dehydrogenase 10. Chem Biol Interact 276:88-94
Mochona, Bereket; Jackson, Timothy; McCauley, DeCoria et al. (2016) Synthesis and Cytotoxic Evaluation of Pyrrole Hetarylazoles Containing Benzimidazole/Pyrazolone/1,3,4-Oxadiazole Motifs. J Heterocycl Chem 53:1871-1877
Engel, Krysta L; French, Sarah L; Viktorovskaya, Olga V et al. (2015) Spt6 Is Essential for rRNA Synthesis by RNA Polymerase I. Mol Cell Biol 35:2321-31
Ayuk-Takem, Lambert; Amissah, Felix; Aguilar, Byron J et al. (2014) Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration. Environ Toxicol 29:466-77
Chougule, Mahavir B; Patel, Apurva R; Patlolla, Ram et al. (2014) Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption. J Drug Target 22:498-508
Culpepper, Bonnie K; Webb, William M; Bonvallet, Paul P et al. (2014) Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains. J Biomed Mater Res A 102:1008-16
Errahali, Younes J; Thomas, Leeshawn D; Keller 3rd, Thomas C S et al. (2013) Inhibition by new glucocorticoid antedrugs [16?, 17?-d] isoxazoline and [16?, 17?-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion. J Interferon Cytokine Res 33:493-507
Stephenson, Adrienne P; Schneider, Jeffrey A; Nelson, Bryant C et al. (2013) Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine. Toxicol Lett 218:299-307
Godugu, Chandraiah; Patel, Apurva R; Doddapaneni, Ravi et al. (2013) Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models. J Control Release 172:86-95

Showing the most recent 10 out of 40 publications